Clinical Trials Directory

Trials / Completed

CompletedNCT03258190

Lime Powder Regimen (LPR) for Prevention of Renal Stone Recurrence

Lime Powder Regimen Supplement Alleviates Urinary Metabolic Abnormalities to Prevent Urolithiasis Recurrence.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
137 (actual)
Sponsor
Chulalongkorn University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Lime powder regimen (LPR) is a lime-derived composition enriches with citrate/citric acid and potassium. LPR was invented to treat the renal stone patients with high risk of stone recurrence after stone removal. LPR should have equal or higher efficacy and lower adverse effect than current standard medicine.

Detailed description

Lime powder regimen (LPR) is a mixture of lime-derive component with adjuvants containing high concentration of citrate, and moderate amount of potassium, magnesium and antioxidants. LPR was tested and verified to be very less toxic in cell culture and animal models. The clinical trial phase II showed that LPR reduced urinary metabolic abnormalities that enhance stone formation, such as hypocitraturia, hypokaliuria and acidified urine. Adverse effect of LPR was very low.

Conditions

Interventions

TypeNameDescription
DRUGLime Powder RegimenLPR and placebo were randomly given to subjects for 6 months

Timeline

Start date
2014-07-01
Primary completion
2018-06-01
Completion
2018-06-30
First posted
2017-08-23
Last updated
2019-02-01

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT03258190. Inclusion in this directory is not an endorsement.